Zimmer Biomet Holdings ZBH Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $424.2M-69.4% | $591.9M+12.6% | $1.29B+127% | $556.9M+32.6% | $1.38B+252% | ||
| $1.73B+12.7% | $1.7B+15.1% | $1.6B+7.9% | $1.61B+13.6% | $1.53B+6.0% | ||
| $2.25B+0.1% | $2.29B+2.3% | $2.48B+4.9% | $2.45B+3.6% | $2.24B-6.0% | ||
| $562.9M+31.5% | $537.3M+24.9% | $460.3M+3.5% | $431.4M0.0% | $428.2M+6.0% | ||
| —— | —— | —— | —— | —— | ||
| $4.96B-11.2% | $5.12B+9.6% | $5.83B+20.0% | $5.05B+8.9% | $5.59B+20.7% | ||
| $2.21B+7.1% | $2.21B+7.7% | $2.19B+4.1% | $2.18B+3.5% | $2.06B-1.2% | ||
| $9.93B+10.5% | $9.95B+11.1% | $9.7B+8.9% | $9.71B+10.0% | $8.99B+2.2% | ||
| $4.55B+1.8% | $4.72B+2.6% | $4.74B+1.6% | $4.89B+3.9% | $4.47B-5.6% | ||
| $249.9M+1,246% | $244.1M-30.8% | -$21.8M-82.8% | -$21.8M-82.8% | -$21.8M-106% | ||
| $1.07B-0.4% | $1.1B+0.4% | $1.02B-13.2% | $1.04B-16.9% | $1.07B-11.0% | ||
| $22.72B+2.4% | $23.09B+8.1% | $23.49B+8.1% | $22.87B+6.3% | $22.18B+3.4% | ||
| $361.2M+19.9% | $303M+55.7% | $315.3M-2.2% | $348.7M+2.0% | $301.3M-18.6% | ||
| $293.9M-78.9% | $477.1M-65.8% | $1.49B-3.2% | $1.53B+10.2% | $1.39B+0.5% | ||
| $1.18B+96.0% | $587.1M-32.0% | $600M-65.0% | $820M-56.3% | $600M-38.1% | ||
| -$7.4M+52.6% | $0— | -$42.7M+44.3% | -$116.4M-21.4% | -$15.6M-122% | ||
| $2.86B+24.8% | $2.58B+5.4% | $2.4B-32.7% | $2.7B-25.2% | $2.29B-18.0% | ||
| $6.3B-4.3% | $6.93B+29.8% | $7.51B+58.6% | $6.75B+70.7% | $6.58B+36.3% | ||
| $630.7M-30.6% | $626.1M-15.9% | $806.4M-21.6% | $878.8M-27.1% | $908.9M+57.5% | ||
| $10.04B+2.7% | $10.39B+16.8% | $10.72B+14.8% | $10.33B+17.8% | $9.78B+10.6% | ||
| $3.2M0.0% | $3.2M0.0% | $3.2M0.0% | $3.2M0.0% | $3.2M0.0% | ||
| $10.2B+1.1% | $10.18B+1.4% | $10.16B+1.4% | $10.11B+1.3% | $10.09B+1.4% | ||
| $11.8B+5.1% | $11.61B+4.6% | $11.52B+5.6% | $11.34B+5.9% | $11.23B+6.9% | ||
| -$190.4M+33.7% | -$205.7M+21.7% | -$283.8M-40.4% | -$284.5M-45.7% | -$287.3M-36.0% | ||
| $9.14B+5.8% | $8.89B+5.8% | $8.64B+3.5% | $8.64B+11.5% | $8.64B+12.9% | ||
| $8.2M-5.7% | $8.1M0.0% | $9.5M+11.8% | $9.3M+10.7% | $8.7M+7.4% | ||
| $12.67B+2.2% | $12.7B+1.8% | $12.76B+3.1% | $12.53B-1.7% | $12.4B-1.6% | ||
| $22.72B+2.4% | $23.09B+8.1% | $23.49B+8.1% | $22.87B+6.3% | $22.18B+3.4% | ||
| $1.07B-0.4% | $1.1B+0.4% | $1.02B-13.2% | $1.04B-16.9% | $1.07B-11.0% | ||
| $4.55B+1.8% | $4.72B+2.6% | $4.74B+1.6% | $4.89B+3.9% | $4.47B-5.6% | ||
| $1.07B-0.4% | $1.1B+0.4% | $1.02B-13.2% | $1.04B-16.9% | $1.07B-11.0% | ||
| $1.07B-0.4% | $1.1B+0.4% | $1.02B-13.2% | $1.04B-16.9% | $1.07B-11.0% | ||
| $293.9M— | $477.1M— | —— | —— | —— | ||
| $293.9M— | $477.1M— | —— | —— | —— | ||
| $1.03B-25.9% | $1.22B-12.7% | $1.49B-3.2% | $1.53B+10.2% | $1.39B+0.5% | ||
| $7.47B+4.1% | $7.75B+20.2% | $8.11B+25.8% | $7.57B+29.8% | $7.18B+23.8% | ||
| $10.2B+1.1% | $10.18B+1.4% | $10.16B+1.4% | $10.11B+1.3% | $10.09B+1.4% | ||
| $3.2M0.0% | $3.2M0.0% | $3.2M0.0% | $3.2M0.0% | $3.2M0.0% | ||
| $9.14B+5.8% | $8.89B+5.8% | $8.64B+3.5% | $8.64B+11.5% | $8.64B+12.9% | ||
| $249.9M— | $244.1M-30.8% | —— | —— | —— | ||
| $8.2M-5.7% | $8.1M0.0% | $9.5M+11.8% | $9.3M+10.7% | $8.7M+7.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Zimmer Biomet Holdings's total assets?
- Zimmer Biomet Holdings (ZBH) holds $22.7B in total assets, up 2.4% year over year.
- How much debt does Zimmer Biomet Holdings have?
- Zimmer Biomet Holdings carries $7.5B in total debt against $12.7B of shareholders' equity, a debt-to-equity ratio of 0.59.
- How much cash does Zimmer Biomet Holdings have?
- Zimmer Biomet Holdings holds $424.2M in cash and equivalents.
- Can Zimmer Biomet Holdings cover its short-term obligations?
- Its current ratio is 1.73 — current assets exceed current liabilities.
- Where does Zimmer Biomet Holdings's balance sheet data come from?
- Every line is extracted from Zimmer Biomet Holdings's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
